
### [MONDO:0017429](http://purl.obolibrary.org/obo/MONDO_0017429)
**Label:** joint formation defects

**Subclasses:** [MONDO:0017556](http://purl.obolibrary.org/obo/MONDO_0017556) (Madelung deformity, unilateral), [MONDO:0017555](http://purl.obolibrary.org/obo/MONDO_0017555) (radio-ulnar synostosis, bilateral), [MONDO:0017467](http://purl.obolibrary.org/obo/MONDO_0017467) (tibio-fibular synostosis), [MONDO:0017985](http://purl.obolibrary.org/obo/MONDO_0017985) (congenital radioulnar synostosis), [MONDO:0017557](http://purl.obolibrary.org/obo/MONDO_0017557) (Madelung deformity, bilateral), [MONDO:0017552](http://purl.obolibrary.org/obo/MONDO_0017552) (Humero-ulnar synostosis, unilateral), [MONDO:0017551](http://purl.obolibrary.org/obo/MONDO_0017551) (Humero-radial synostosis, bilateral), [MONDO:0017983](http://purl.obolibrary.org/obo/MONDO_0017983) (Humero-radio-ulnar synostosis), [MONDO:0017554](http://purl.obolibrary.org/obo/MONDO_0017554) (radio-ulnar synostosis, unilateral), [MONDO:0017553](http://purl.obolibrary.org/obo/MONDO_0017553) (Humero-ulnar synostosis, bilateral), [MONDO:0009356](http://purl.obolibrary.org/obo/MONDO_0009356) (autosomal recessive humeroradial synostosis), [MONDO:0019782](http://purl.obolibrary.org/obo/MONDO_0019782) (humero-ulnar synostosis), [MONDO:0018154](http://purl.obolibrary.org/obo/MONDO_0018154) (Madelung deformity), [MONDO:0009357](http://purl.obolibrary.org/obo/MONDO_0009357) (humeroradial synostosis with craniofacial anomalies), [MONDO:0017550](http://purl.obolibrary.org/obo/MONDO_0017550) (Humero-radial synostosis, unilateral), [MONDO:0007737](http://purl.obolibrary.org/obo/MONDO_0007737) (humeroradial synostosis (disease)), [MONDO:0008509](http://purl.obolibrary.org/obo/MONDO_0008509) (distal symphalangism (disease)), [MONDO:0007343](http://purl.obolibrary.org/obo/MONDO_0007343) (isolated congenital digital clubbing), [MONDO:0017549](http://purl.obolibrary.org/obo/MONDO_0017549) (Humero-radio-ulnar synostosis, bilateral), [MONDO:0017548](http://purl.obolibrary.org/obo/MONDO_0017548) (Humero-radio-ulnar synostosis, unilateral), 

**Mapped go classes:** [GO:0016404](http://purl.obolibrary.org/obo/GO_0016404) (15-hydroxyprostaglandin dehydrogenase (NAD+) activity), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0004957](http://purl.obolibrary.org/obo/GO_0004957) (prostaglandin E receptor activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 54.17%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 54.17%
- Thing 52.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 39.52%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005377](http://purl.obolibrary.org/obo/GO_0005377) (obsolete intracellular copper ion transporter) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005376](http://purl.obolibrary.org/obo/GO_0005376) (obsolete plasma membrane copper transporter) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005373](http://purl.obolibrary.org/obo/GO_0005373) (obsolete heavy metal ion porter activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005370](http://purl.obolibrary.org/obo/GO_0005370) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005361](http://purl.obolibrary.org/obo/GO_0005361) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005349](http://purl.obolibrary.org/obo/GO_0005349) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005348](http://purl.obolibrary.org/obo/GO_0005348) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005341](http://purl.obolibrary.org/obo/GO_0005341) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005339](http://purl.obolibrary.org/obo/GO_0005339) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005336](http://purl.obolibrary.org/obo/GO_0005336) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 39.52%


